International cosmetic company, Labo, has launched two of its cosmetic products; Crescina and Fillerina on the Kenyan market through Medipoint Pharmaceuticals.
Fillerina is an anti-skin ageing product that was produced following a study by Labo on skin ageing and skin biological process that saw it being granted 9 specific formulation patents.
In 2012, the product was introduced as a real breakthrough in skin filling technology.
“Fillerina has two major functions; to correct wrinkles; these are expression lines and deep furrows that form on the skin, and to improve the microrelief; these are the aging lines and fine lines; as well as give new volumes to cheekbones, lips etcetera,” Said Mr. Godfrey Wambaa, the Managing Director of Medipoint Pharmaceuticals. As skin ages, the amount of hyaluronic acid gradually declines, causing imperfections such as ageing wrinkles, expression lines and loss of volume; that is, deflation and skin depressions, especially as regards to cheekbones, cheeks and lips.
“Fillerina comes in three grades. Grade 1 is for moderate age wrinkles and expression line, Grade 2 for visible age wrinkles and expression lines, market, uneven microrelief, areas with visible sagging especially cheekbones and lips, and Grade 3 that is for deep age wrinkles and expression lines, very market, uneven microrelief and severe sagging of facial features, especially cheekbones and lips,” said Mr. Wambaa.
Crescina, on the other hand is a hair treatment product that comes in two formulations that is suitable for hair thinning and prevention of hair loss. Crescina Re-Growth is suitable for hair thinning while Crescina Anti-Hair Loss is suitable in preventing hair loss.
o“People think that hair loss is only associated with men. What they do not know is that, hair loss is a phenomenon that occurs both in men and women and that it is something that can be treated and prevented,” said Dr. Jacque Kavete, a Clinical Dermatologist at Kenyatta National Hospital.
The concentrations of Crescina Re-Growth active ingredients were developed according to the stages of thinning listed in the Hamilton/Ludwig scale, created by Labo researchers.
While introducing Labo to Kenya, Mr. Manuel Falsarella, who is the International Sales Manager at Labo International, said the company has presence in more than 30 countries with the African continent represented by Kenya and South Africa.
Labo Cosprophar Suisse, a Swiss trademark registered in 1989, is pursuing the mission of devoting heavy investments to research to find and patent innovative cosmetic products that are highly beneficial for the consumer.
The goal is to make them leaders, especially in prominent markets such as hair and skin care. Labo International is the sales branch established in Italy in 1996 to directly manage investments on the European and world market.
Production sites are both in Switzerland and Italy, whereas sales distribution is set up and managed directly by Labo International through a network of exclusive distributors. The Labo trademark is found in 43 Countries.